Greenwich LifeSciences's total assets for Q1 2025 were $2.75M, a decrease of -32.80% from the previous quarter. GLSI total liabilities were $1.44M for the fiscal quarter, a -7.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.